ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 628917 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 628917; 2) Community: the network communities that were significantly associated with the response to NSC 628917; 3) Molecule: the relationships between components within communities and NSC 628917; 4) MDR: the compounds that were significantly associated with the NSC 628917.

NSC Compound Enrichment Correlation
NSC 692348 Null 0.000601164336889762 0.42997724
NSC 701383 Null 0.000601164336889762 0.51836595
NSC 722867 Null 0.000601164336889762 0.19158507
NSC 723732 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one 0.000601164336889762 0.38915497
NSC 735373 Bis{(5,6-dihydro-5,11-diketo-2,3-dimethoxy-11H-indeno[1,2-c] isoquinoline)-6-propylamino}propane Bis(trifluoroacetate) 0.000601164336889762 0.56850494
NSC 359466 Null 0.00070132188671658 0.56912758
NSC 638748 Tetrakis(8-chinolineolato)titanium(IV)-tetrahydrochloride 0.000880521445136051 0.43352581
NSC 645317 Sanguilutine pseudobase 0.000880521445136051 0.42104237
NSC 671316 Null 0.000880521445136051 0.54731908
NSC 691844 Null 0.000880521445136051 0.56975798
Total:106  Current:4    [First] [Prev] [Next] [Last]